"We are very fortunate to have Marc join as our new Chairman of our Supervisory Board, as he has great experience and a keen understanding of the biotechnology industry in general and cell therapy in particular. We are convinced that Marc has the business acumen and leadership skills to support TxCell’s strategic development," commented Frederic Hammel, TxCell's CEO.
"I am excited and honored to be joining TxCell," stated Marc Beer, the newly appointed Chairman of the Supervisory Board. "I believe in TxCell’s long-term potential benefits for patients with chronic diseases. I look forward to working with the team to forge the road ahead", he added.
About Marc D. Beer
Marc D. Beer joined Cambridge MA-based ViaCell as its Chief Executive Officer in April 2000 and developed the cell screening company through several rounds of private and stock market financing before organizing its acquisition by PerkinElmer Inc. Prior to ViaCell, Marc held a number of senior management positions at Genzyme, most recently serving as Vice President, Global Marketing for Genzyme Therapeutics. Before that, Mr Beer held a variety of management roles at BioStar Inc. and Abbott Laboratories. Marc Beer has more than 20 years' experience in P&L management, sales & marketing and R&D management in therapeutic, surgical and in vitro diagnostics businesses. Mr. Beer received his B.S. in Business Administration from Miami University, Oxford, in 1987
About TxCell
TxCell SA was spun out of INSERM (France's National Institute for Health and Medical Research) in 2001. The company develops novel cell therapies for autoimmune and chronic inflammatory diseases based on the biological properties of regulatory T lymphocytes (Tr1 cells). In 2007, the AFSSAPS (the French Agency for Health Product Safety) authorized the company to start its first clinical trial of a Tr1 lymphocyte-based therapy in Crohn's disease. The first results are expected at the end of this year. The firm is based in the Sophia Antipolis technology park, near Nice in southern France. TxCell has recently moved into new premises that are better suited to its future growth. www.txcell.com
Contacts
TxCell: David Dellamonica dellamonica@txcell.com Tel: +33(0) 497 218 300
ALIZE RP Caroline Carmagnol caroline@alizerp.com Tel : + 33 (0) 664 189 959 Juliette Vandenbroucque juliette@alizerp.com Tel : + 33 (0)1 41 22 07 32
